Perspective Therapeutics (CATX) Revenue (2010 - 2023)

Perspective Therapeutics has disclosed Revenue across 14 years of filings, most recently posting -$4.9 million for Q4 2023.

• Revenue for Q4 2023 came in at -$4.9 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2023 was $613000.0 (changed N/A YoY), and the FY2023 annual result was $1.4 million, changed N/A from the prior year.
• Revenue came in at -$4.9 million for Q4 2023 at Perspective Therapeutics, down from $2.2 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $2.9 million in Q1 2022 to a low of -$4.9 million in Q4 2023.
• The 5-year median for Revenue is $2.3 million (2019), against an average of $1.9 million.
• Across the five-year window, Revenue jumped 49.69% in 2020 and plunged 40.12% in 2023, its largest moves.
• Perspective Therapeutics' Revenue stood at $2.2 million in 2019, then advanced by 6.94% to $2.4 million in 2020, then increased by 19.37% to $2.8 million in 2021, then tumbled by 39.03% to $1.7 million in 2022, then sank by 385.5% to -$4.9 million in 2023.
• The last three Revenue figures came in at -$4.9 million (Q4 2023), $2.2 million (Q3 2023), and $1.5 million (Q2 2023), per Business Quant data.